European drug pricing: Jam tomorrow, log-jam today
This article was originally published in Scrip
Executive Summary
The European Parliament has agreed on potential changes to outdated European legislation that if approved could eventually bring generic medicines to the market more quickly. However, the end is by no means in sight as EU member states are still to thrash out their position on the revision, and ministers in the national governments of the European Union are understood to have a number of concerns about its contents.